10.1021/acsmedchemlett.3c00256 281 TomitaM.HayashiM.AwazuS
When to Talk to a Medical Provider About Weight Maintenance Additional guidance may be helpful if you notice: rapid weight regain persistent hunger difficulty maintaining habits changes in energy levels metabolic health concerns Professional support can provide structure and personalized strategies
April 2022: EMA's human medicines committee (CHMP) has recommended two diabetes mellitus treatments, Actrapid and Insulatard, for use outside the European Union (EU)
When to Contact Your Prescriber Self-injection technique issues that warrant a clinical call include: a lump or hardened area at the injection site that persists for more than 2 weeks (possible lipohypertrophy), signs of infection (expanding redness, warmth, pus, or fever), allergic reaction at the site (hives, intense itching, or swelling beyond 2 inches), and any systemic symptoms such as severe abdominal pain, persistent vomiting, or signs of pancreatitis